Last update 01 Nov 2024

Deli (Zhejiang) Pharmaceutical Co., Ltd.

Private Company|
2021|
Zhejiang Sheng, China
|
www.antengene.com

Overview

Related

1
Drugs associated with Deli (Zhejiang) Pharmaceutical Co., Ltd.
CB-708
Target
CD73
Mechanism
CD73 inhibitors
Active Org.
Antengene Corp. Ltd.Antengene Corp. Ltd. [+3]
Originator Org.
Calithera Biosciences, Inc.Calithera Biosciences, Inc.
Active Indication
Advanced Malignant Solid Neoplasm [+6]
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Deli (Zhejiang) Pharmaceutical Co., Ltd.
CTR20223400 / RecruitingPhase 1
一项评估 ATG-037 单药和联合帕博利珠单抗用于治疗局部晚期或转移性实体瘤患者的安全性、药代动力学、药效学和初步有效性的 I/Ib 期、多中心、开放性和剂量探索的临床研究
[Translation] A Phase I/Ib, multicenter, open-label, dose-finding study evaluating the safety, pharmacokinetics, pharmacodynamics, and preliminary efficacy of ATG-037 alone and in combination with pembrolizumab in patients with locally advanced or metastatic solid tumors
100 Clinical Results associated with Deli (Zhejiang) Pharmaceutical Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Deli (Zhejiang) Pharmaceutical Co., Ltd.
Login to view more data
100 Deals associated with Deli (Zhejiang) Pharmaceutical Co., Ltd.
Login to view more data
100 Translational Medicine associated with Deli (Zhejiang) Pharmaceutical Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
IND Approval
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
CB-708
 ( CD73 )		Neoplasms
More
IND Approval
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free